MAY 26, 2015 09:00 AM PDT

Intelligent NGS Assay Design: Oncomine™ Focus Assay for NGS clinical research in oncology

Speakers
  • Director of Oncology, Research & Development, Thermo Fisher Scientific
    Biography
      Seth Sadis is the Director of Oncology, Research & Development in the Genetic, Applied, and Medical Sciences Division of Thermo Fisher Scientific.

      Currently Dr . Sadis leads a team of Software Engineers, Bioinformaticists and Translational Oncology scientists to develop both research assays and diagnostic tests on the Ion TorrentÔ next generation sequencing platform, capillary electrophoresis sequencing systems, as well as qPCR and digital PCR platforms.

      Dr. Sadis earned a Ph.D in Biochemistry and completed a postdoctoral fellowship at Harvard Medical School. His professional career includes 15 years in biopharma industry, spanning oncology drug discovery through clinical development and diagnostics.

    Abstract:
    DATE: Tuesday, May 26th, 2015
    TIME: 09:00AM PDT, 12:00PM EDT

    Next-generation sequencing (NGS) is changing the landscape of clinical research. This powerful technology is enabling researchers to move from running many sequential tests to a single workflow that provides DNA and RNA results across many genes with the detection of relevant SNPs, CNVs, gene fusions and indels.

    Learn how our NGS experts are impacting research today and gain valuable insights into their assay design process.


    We will cover the following:
    - Overview of Oncomine™ Assay products
    - Oncomine™ Assay design approach
    - Performance and results

    Show Resources
    You May Also Like
    AUG 16, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 16, 2018 08:00 AM PDT
    DATE: August, 16, 2018TIME: 08:00AM PDTThis webinar will review recent advancements in the application of next-generation sequencing of T cell receptor beta (TCRB) chain repertoires towards...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 24, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    Loading Comments...